Literature DB >> 29237835

HLA Class I-Mediated HIV-1 Control in Vietnamese Infected with HIV-1 Subtype A/E.

Takayuki Chikata1, Giang Van Tran1,2, Hayato Murakoshi1, Tomohiro Akahoshi1, Ying Qi3, Vivek Naranbhai3,4,5, Nozomi Kuse1, Yoshiko Tamura1, Madoka Koyanagi1, Sachiko Sakai1, Dung Hoai Nguyen2, Dung Thi Nguyen2, Ha Thu Nguyen2, Trung Vu Nguyen2, Shinichi Oka1,6, Maureen P Martin3,5, Mary Carrington3,5, Keiko Sakai1, Kinh Van Nguyen2, Masafumi Takiguchi7.   

Abstract

HIV-1-specific cytotoxic T cells (CTLs) play an important role in the control of HIV-1 subtype B or C infection. However, the role of CTLs in HIV-1 subtype A/E infection still remains unclear. Here we investigated the association of HLA class I alleles with clinical outcomes in treatment-naive Vietnamese infected with subtype A/E virus. We found that HLA-C*12:02 was significantly associated with lower plasma viral loads (pVL) and higher CD4 counts and that the HLA-A*29:01-B*07:05-C*15:05 haplotype was significantly associated with higher pVL and lower CD4 counts than those for individuals without these respective genotypes. Nine Pol and three Nef mutations were associated with at least one HLA allele in the HLA-A*29:01-B*07:05-C*15:05 haplotype, with a strong negative correlation between the number of HLA-associated Pol mutations and CD4 count as well as a positive correlation with pVL for individuals with these HLA alleles. The results suggest that the accumulation of mutations selected by CTLs restricted by these HLA alleles affects HIV control.IMPORTANCE Most previous studies on HLA association with disease progression after HIV-1 infection have been performed on cohorts infected with HIV-1 subtypes B and C, whereas few such population-based studies have been reported for cohorts infected with the Asian subtype A/E virus. In this study, we analyzed the association of HLA class I alleles with clinical outcomes for 536 HIV-1 subtype A/E-infected Vietnamese individuals. We found that HLA-C*12:02 is protective, while the HLA haplotype HLA-A*29:01-B*07:05-C*15:05 is deleterious. The individuals with HIV-1 mutations associated with at least one of the HLA alleles in the deleterious HLA haplotype had higher plasma viral loads and lower CD4 counts than those of individuals without the mutations, suggesting that viral adaptation and escape from HLA-mediated immune control occurred. The present study identifies a protective allele and a deleterious haplotype for HIV-1 subtype A/E infection which are different from those identified for cohorts infected with HIV-1 subtypes B and C.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  HIV-1; HLA class I; HLA-associated mutation; Vietnam; clinical outcome; deleterious allele; protective allele; subtype A/E

Mesh:

Substances:

Year:  2018        PMID: 29237835      PMCID: PMC5809730          DOI: 10.1128/JVI.01749-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  HLA and AIDS: a cautionary tale.

Authors:  S J O'Brien; X Gao; M Carrington
Journal:  Trends Mol Med       Date:  2001-09       Impact factor: 11.951

Review 2.  Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.

Authors:  L Buonaguro; M L Tornesello; F M Buonaguro
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

3.  Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

Authors:  Hayato Murakoshi; Tomohiro Akahoshi; Madoka Koyanagi; Takayuki Chikata; Takuya Naruto; Rie Maruyama; Yoshiko Tamura; Naoki Ishizuka; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  HLA class I-mediated control of HIV-1 in the Japanese population, in which the protective HLA-B*57 and HLA-B*27 alleles are absent.

Authors:  Takuya Naruto; Hiroyuki Gatanaga; George Nelson; Keiko Sakai; Mary Carrington; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

5.  Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.

Authors:  Philippa C Matthews; Madoka Koyanagi; Henrik N Kløverpris; Mikkel Harndahl; Anette Stryhn; Tomohiro Akahoshi; Hiroyuki Gatanaga; Shinichi Oka; Claudia Juarez Molina; Humberto Valenzuela Ponce; Santiago Avila Rios; David Cole; Jonathan Carlson; Rebecca P Payne; Anthony Ogwu; Alfred Bere; Thumbi Ndung'u; Kamini Gounder; Fabian Chen; Lynn Riddell; Graz Luzzi; Roger Shapiro; Christian Brander; Bruce Walker; Andrew K Sewell; Gustavo Reyes Teran; David Heckerman; Eric Hunter; Søren Buus; Masafumi Takiguchi; Philip J R Goulder
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

6.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

Authors:  M Carrington; G W Nelson; M P Martin; T Kissner; D Vlahov; J J Goedert; R Kaslow; S Buchbinder; K Hoots; S J O'Brien
Journal:  Science       Date:  1999-03-12       Impact factor: 47.728

7.  Additive contribution of HLA class I alleles in the immune control of HIV-1 infection.

Authors:  Alasdair Leslie; Philippa C Matthews; Jennifer Listgarten; Jonathan M Carlson; Carl Kadie; Thumbi Ndung'u; Christian Brander; Hoosen Coovadia; Bruce D Walker; David Heckerman; Philip J R Goulder
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

8.  HLA Class I Alleles Associated with Mortality in Thai Military Recruits with HIV-1 CRF01_AE Infection.

Authors:  Rajesh T Gandhi; Ronald J Bosch; Ram Rangsin; Thippawan Chuenchitra; Narongrid Sirisopana; Jerome H Kim; Merlin L Robb; Sasijit Vejbaesya; Robert M Paris; Kenrad E Nelson
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-18       Impact factor: 2.205

Review 9.  The influence of HLA genotype on AIDS.

Authors:  Mary Carrington; Stephen J O'Brien
Journal:  Annu Rev Med       Date:  2001-12-03       Impact factor: 13.739

10.  Control of HIV-1 by an HLA-B*52:01-C*12:02 Protective Haplotype.

Authors:  Takayuki Chikata; Hayato Murakoshi; Madoka Koyanagi; Kazutaka Honda; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Infect Dis       Date:  2017-12-12       Impact factor: 5.226

View more
  10 in total

1.  Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.

Authors:  Ming-Han Chloe Tsai; Supriya Singh; Emily Adland; Philip Goulder
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 2.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

3.  Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.

Authors:  Yosuke Maeda; Taichiro Takemura; Takayuki Chikata; Takeo Kuwata; Hiromi Terasawa; Riito Fujimoto; Nozomi Kuse; Tomohiro Akahoshi; Hayato Murakoshi; Giang Van Tran; Yu Zhang; Chau Ha Pham; Anh Hong Quynh Pham; Kazuaki Monde; Tomohiro Sawa; Shuzo Matsushita; Trung Vu Nguyen; Kinh Van Nguyen; Futoshi Hasebe; Tetsu Yamashiro; Masafumi Takiguchi
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

Review 4.  Association of Diverse Genotypes and Phenotypes of Immune Cells and Immunoglobulins With the Course of HIV-1 Infection.

Authors:  Liuzhe Li; Yan Liu; Miroslaw K Gorny
Journal:  Front Immunol       Date:  2018-11-26       Impact factor: 7.561

5.  Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach.

Authors:  Takayuki Chikata; Wayne Paes; Tomohiro Akahoshi; Thomas Partridge; Hayato Murakoshi; Hiroyuki Gatanaga; Nicola Ternette; Shinichi Oka; Persephone Borrow; Masafumi Takiguchi
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

6.  Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.

Authors:  Takayuki Chikata; Wayne Paes; Nozomi Kuse; Thomas Partridge; Hiroyuki Gatanaga; Yu Zhang; Kimiko Kuroki; Katsumi Maenaka; Nicola Ternette; Shinichi Oka; Persephone Borrow; Masafumi Takiguchi
Journal:  J Virol       Date:  2022-04-27       Impact factor: 6.549

7.  Control of HIV-1 Replication by CD8+ T Cells Specific for Two Novel Pol Protective Epitopes in HIV-1 Subtype A/E Infection.

Authors:  Hung The Nguyen; Nozomi Kuse; Yu Zhang; Hayato Murakoshi; Yosuke Maeda; Yoshiko Tamura; Rie Maruyama; Giang Van Tran; Trung Vu Nguyen; Kinh Van Nguyen; Shinichi Oka; Takayuki Chikata; Masafumi Takiguchi
Journal:  J Virol       Date:  2022-09-26       Impact factor: 6.549

8.  HIV-1-Associated Neurocognitive Disorders: Is HLA-C Binding Stability to β2-Microglobulin a Missing Piece of the Pathogenetic Puzzle?

Authors:  Donato Zipeto; Michela Serena; Simona Mutascio; Francesca Parolini; Erica Diani; Elisabetta Guizzardi; Valentina Muraro; Emanuela Lattuada; Sebastiano Rizzardo; Marina Malena; Massimiliano Lanzafame; Giovanni Malerba; Maria Grazia Romanelli; Stefano Tamburin; Davide Gibellini
Journal:  Front Neurol       Date:  2018-09-21       Impact factor: 4.003

9.  Critical effect of Pol escape mutations associated with detrimental allele HLA-C*15: 05 on clinical outcome in HIV-1 subtype A/E infection.

Authors:  Hayato Murakoshi; Takayuki Chikata; Tomohiro Akahoshi; Chengcheng Zou; Mohamed Ali Borghan; Giang Van Tran; Trung Vu Nguyen; Kinh Van Nguyen; Nozomi Kuse; Masafumi Takiguchi
Journal:  AIDS       Date:  2021-01-01       Impact factor: 4.632

10.  Role of Escape Mutant-Specific T Cells in Suppression of HIV-1 Replication and Coevolution with HIV-1.

Authors:  Yu Zhang; Nozomi Kuse; Tomohiro Akahoshi; Takayuki Chikata; Hiroyuki Gatanaga; Shinichi Oka; Hayato Murakoshi; Masafumi Takiguchi
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.